US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist
  • 14.480
  • +0.910+6.71%
Close Jul 12 16:00 ET
  • 14.480
  • 0.0000.00%
Post 16:02 ET
718.91MMarket Cap-7916P/E (TTM)

Mineralys Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
136.73%35.36M
168.93%84.66M
176.89%27.71M
253.94%26.27M
142.86%15.74M
97.36%14.94M
68.11%31.48M
41.30%10.01M
7.42M
6.48M
Selling and administrative expenses
74.22%4.61M
173.40%14.3M
83.84%4.03M
176.69%3.77M
335.63%3.85M
234.39%2.65M
116.34%5.23M
368.95%2.19M
--1.36M
--884K
-General and administrative expense
74.22%4.61M
173.40%14.3M
83.84%4.03M
176.69%3.77M
335.63%3.85M
234.39%2.65M
116.34%5.23M
368.95%2.19M
--1.36M
--884K
Research and development costs
150.17%30.75M
168.04%70.36M
202.95%23.69M
271.33%22.5M
112.40%11.88M
81.37%12.29M
60.96%26.25M
18.17%7.82M
--6.06M
--5.6M
Operating profit
-136.73%-35.36M
-168.93%-84.66M
-176.89%-27.71M
-253.94%-26.27M
-142.86%-15.74M
-97.36%-14.94M
-68.11%-31.48M
-41.30%-10.01M
-7.42M
-6.48M
Net non-operating interest income expense
65.44%3.85M
661.10%12.76M
255.19%3.32M
374.09%3.51M
3.59M
2.33M
6,307.41%1.68M
935K
741K
0
Non-operating interest income
65.44%3.85M
661.10%12.76M
255.19%3.32M
374.09%3.51M
--3.59M
--2.33M
--1.68M
--935K
--741K
--0
Other net income (expense)
0.00%1K
-25.00%3K
1K
1K
1K
100.61%4K
0
4K
Other non- operating income (expenses)
0.00%1K
-25.00%3K
--1K
----
--1K
--1K
300.00%4K
--0
--4K
----
Income before tax
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
-6.68M
-6.48M
Income tax
Net income
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
-6.68M
-6.48M
Net income continuous Operations
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
---6.68M
---6.48M
Minority interest income
Net income attributable to the parent company
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
-6.68M
-6.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
-53.54%-29.8M
-28.10%-9.07M
-6.68M
-6.48M
Basic earnings per share
-37.25%-0.7
-160.82%-1.99
-171.20%-0.63
55.81%-0.57
75.21%-0.31
65.09%-0.51
79.74%-0.763
83.01%-0.2323
-1.29
-1.2504
Diluted earnings per share
-37.25%-0.7
-160.82%-1.99
-171.20%-0.63
55.81%-0.57
75.21%-0.31
65.09%-0.51
79.74%-0.763
83.01%-0.2323
-1.29
-1.2504
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 136.73%35.36M168.93%84.66M176.89%27.71M253.94%26.27M142.86%15.74M97.36%14.94M68.11%31.48M41.30%10.01M7.42M6.48M
Selling and administrative expenses 74.22%4.61M173.40%14.3M83.84%4.03M176.69%3.77M335.63%3.85M234.39%2.65M116.34%5.23M368.95%2.19M--1.36M--884K
-General and administrative expense 74.22%4.61M173.40%14.3M83.84%4.03M176.69%3.77M335.63%3.85M234.39%2.65M116.34%5.23M368.95%2.19M--1.36M--884K
Research and development costs 150.17%30.75M168.04%70.36M202.95%23.69M271.33%22.5M112.40%11.88M81.37%12.29M60.96%26.25M18.17%7.82M--6.06M--5.6M
Operating profit -136.73%-35.36M-168.93%-84.66M-176.89%-27.71M-253.94%-26.27M-142.86%-15.74M-97.36%-14.94M-68.11%-31.48M-41.30%-10.01M-7.42M-6.48M
Net non-operating interest income expense 65.44%3.85M661.10%12.76M255.19%3.32M374.09%3.51M3.59M2.33M6,307.41%1.68M935K741K0
Non-operating interest income 65.44%3.85M661.10%12.76M255.19%3.32M374.09%3.51M--3.59M--2.33M--1.68M--935K--741K--0
Other net income (expense) 0.00%1K-25.00%3K1K1K1K100.61%4K04K
Other non- operating income (expenses) 0.00%1K-25.00%3K--1K------1K--1K300.00%4K--0--4K----
Income before tax -149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M-6.68M-6.48M
Income tax
Net income -149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M-6.68M-6.48M
Net income continuous Operations -149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M---6.68M---6.48M
Minority interest income
Net income attributable to the parent company -149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M-6.68M-6.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M-53.54%-29.8M-28.10%-9.07M-6.68M-6.48M
Basic earnings per share -37.25%-0.7-160.82%-1.99-171.20%-0.6355.81%-0.5775.21%-0.3165.09%-0.5179.74%-0.76383.01%-0.2323-1.29-1.2504
Diluted earnings per share -37.25%-0.7-160.82%-1.99-171.20%-0.6355.81%-0.5775.21%-0.3165.09%-0.5179.74%-0.76383.01%-0.2323-1.29-1.2504
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg